Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04946864
Title A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.